Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
ABBV [NYSE]
AbbVie Inc.
IndexS&P 500 P/E21.35 EPS (ttm)2.59 Insider Own0.10% Shs Outstand1.59B Perf Week4.64%
Market Cap88.04B Forward P/E14.27 EPS next Y3.88 Insider Trans36.52% Shs Float1.57B Perf Month2.39%
Income4.17B PEG2.31 EPS next Q0.77 Inst Own80.90% Short Float4.04% Perf Quarter4.05%
Sales19.26B P/S4.57 EPS this Y-23.10% Inst Trans16.10% Short Ratio6.51 Perf Half Y9.81%
Book/sh3.27 P/B16.91 EPS next Y22.74% ROA14.50% Target Price67.13 Perf Year31.80%
Cash/sh6.43 P/C8.59 EPS next 5Y9.23% ROE92.70% 52W Range40.86 - 57.83 Perf YTD7.28%
Dividend1.68 P/FCF39.55 EPS past 5Y0.00% ROI23.20% 52W High-5.26% Beta-
Dividend %3.04% Quick Ratio2.70 Sales past 5Y- Gross Margin76.40% 52W Low34.09% ATR1.05
Employees25000 Current Ratio2.80 Sales Q/Q5.00% Oper. Margin31.20% RSI (14)57.48 Volatility1.65% 1.67%
OptionableYes Debt/Eq2.83 EPS Q/Q3.00% Profit Margin21.70% Rel Volume0.74 Prev Close55.29
ShortableYes LT Debt/Eq2.77 EarningsJul 25 BMO Payout61.80% Avg Volume9.77M Price54.79
Recom1.80 SMA202.57% SMA501.16% SMA2007.31% Volume1,100,778 Change-0.90%
28-Jul-14Upgrade UBS Neutral → Buy $57 → $67
24-Jun-14Reiterated Argus Buy $59 → $65
06-Jan-14Reiterated UBS Neutral $46 → $56
29-Oct-13Reiterated Argus Buy $52 → $59
12-Aug-13Initiated Argus Buy $52
15-May-13Reiterated R. F. Lafferty Buy $47.90 → $61
29-Apr-13Reiterated Barclays Equal Weight $41 → $44
15-Apr-13Reiterated Barclays Equal Weight $37 → $41
18-Aug-14 12:43PM  [video] Latest motif: Tax inversion targets at CNBC
11:00AM  AbbVie Cystic Fibrosis Scholarship Program Awards 40 Student Scholars With Annual Academic Awards PR Newswire
12:00AM  UK Says Sovaldi Is Worth It. We Should Listen. at Forbes
15-Aug-14 07:02PM  Abbott, AbbVie Win Dismissal of Suit Over Depakote Marketing at Bloomberg
06:10PM  Biotech Leader Gilead Sciences Scores Sovaldi Win at Investor's Business Daily
05:44PM  Gilead Wins Sovaldi Dispute With Roche, U.K. Nod at Investor's Business Daily
03:12PM  INVESTOR ALERT: Investigation of AbbVie Inc. Announced by The Wagner Firm Business Wire
01:51PM  IRS to probe Valeant tax returns after Canada deal at Financial Times
01:04PM  ABBVIE INC. Financials EDGAR Online Financials
12:23PM  Gilead Wins Sovaldi Dispute With Roche, U.K. Nod at Investor's Business Daily
14-Aug-14 11:13AM  Schumer Details Interest Deduction Limits in Inversions at Bloomberg
13-Aug-14 02:37PM  [video] Tax inversion hot spots at CNBC
12:58PM  AbbVie-Shire Deal Still Offers Big Tax Savings Even Without an Inversion at The Wall Street Journal
10:49AM  Pharmacyclics Has Edge Over Blood Cancer Competitors at TheStreet
09:40AM  [video] Faber Report: New wave of tax inversions? at CNBC
11-Aug-14 02:33PM  Cannabis Should Be Treated as an Agricultural Commodity, Not a Biotech Investment Accesswire
01:03PM  3 Health Care Stocks Nudging The Sector Higher at TheStreet
08-Aug-14 04:45PM  GW Pharma, Insys Face Off In Cannabis Drug Space at Investor's Business Daily
01:50PM  US groups ponder the great tax escape at Financial Times
01:05PM  Shire drops on doubt over AbbVie takeover at Financial Times
07:07AM  Biotech firm Galapagos says GSK stops joint drug project Reuters
07-Aug-14 09:40PM  Stampede of Mergers Could Mean Growth, or Irrationality, Ahead at New York Times
05:03PM  ABBVIE INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
10:00AM  Obama Joins Blame Game As Companies Flee U.S. For Lower Tax Rates at Forbes
06-Aug-14 09:59PM  Obama: Congress should end 'tax inversions' at USA TODAY
04:15PM  Walgreen Stays in U.S. as It Buys Rest of Alliance Boots Bloomberg
01:46PM  [$$] Billions Vaporized as Merger Deals Fall Apart at Barrons.com
01:43PM  Pharma shares slide on fears of 'tax inversion' clampdown at Financial Times
10:15AM  Walgreen Leads Sell-Off In 'Tax Inversion' Stocks at Investor's Business Daily
10:15AM  Walgreen Dives As Drugstore Buys Boots Without Tax Shift Investor's Business Daily
09:36AM  Walgreens drops tax plan, will stay in Chicago at USA TODAY
09:05AM  Walgreen Stays in U.S. as It Buys Rest of Alliance Boots Bloomberg
09:05AM  Walgreens drops tax plan, will stay in Chicago at USA TODAY
08:35AM  Shire shares slide on fears of 'tax inversion' clampdown at Financial Times
08:27AM  Walgreens drops tax plan, will stay in Chicago at USA TODAY
07:41AM  Walgreens to stay rooted in U.S. as it buys Alliance Boots at CNNMoney.com
05-Aug-14 08:09PM  Reports: Walgreens won't tap lucrative tax loophole at USA TODAY
07:28PM  Obama Is Considering Bypassing Congress To Try To Stop Companies From Leaving America To Save On Taxes Business Insider
06:22PM  Reports: Walgreens won't tap lucrative tax loophole at USA TODAY
06:04PM  Reports: Walgreens won't tap lucrative tax loophole at USA TODAY
05:38PM  Drug company won't appeal gay rights ruling to top U.S. court Reuters
04:50PM  AbbVie's ABT-414 Receives Orphan Drug Status in U.S. and EU Zacks
04:36PM  Delamaide: Tax issue shows Congress' failure at USA TODAY
04:13PM  Report: Walgreens won't tap lucrative tax loophole at USA TODAY
04:03PM  Delamaide: Tax issue shows Congress' failure at USA TODAY
03:26PM  Walgreen Seen Rejecting Tax Inversion Amid Pressure at Investor's Business Daily
12:11PM  Obama Weighing Options to Stop Corporate Tax Flight at New York Times
12:11PM  Obama Studying Administrative Action on Corporate Inversions at New York Times
12:11PM  Democrats Ask Obama to Act on Corporate Inversions at New York Times
12:11PM  Democrats Ask Obama to Act on Corporate Inversions at New York Times
09:35AM  Cannabis Technologies Looks to Capitalize on Therapeutics Accesswire
02:38AM  Altogether Now: U.S. Tax Code Is A Rotting Carcass at Forbes
02:38AM  All Together Now: U.S. Tax Code Is A Rotting Carcass at Forbes
04-Aug-14 12:29PM  Walgreen Names New CFO Ahead of Possible Inversion at Investor's Business Daily
10:56AM  Amgen Cancer Drug Kyprolis Succeeds In Trial at Investor's Business Daily
09:08AM  Goldman Sachs hires former Barclays M&A banker at MarketWatch
08:29AM  [$$] AbbVie Brain Tumor Treatment Gets Orphan Designation at The Wall Street Journal
08:00AM  AbbVie Receives EMA and FDA Orphan Drug Designation for Investigational Compound ABT-414 in the Treatment of Glioblastoma Multiforme PR Newswire
01-Aug-14 12:35PM  Pharmacyclics Q2 Earnings Get Mixed Reception at Investor's Business Daily
10:00AM  AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program PR Newswire
31-Jul-14 01:30PM  Drug pricing: Bitter pill at Financial Times
09:42AM  Moving overseas is a last resort for U.S. companies Yahoo Finance
08:26AM  The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene Zacks
04:06AM  AstraZeneca raises forecasts after seeing off Pfizer Reuters
30-Jul-14 02:56AM  More People -- And Now Companies -- Exit U.S. Taxes at Forbes
02:56AM  More People - And Now Companies - Exit U.S. Taxes at Forbes
29-Jul-14 02:36PM  Democrats urge no U.S. contracts for corporate tax 'deserters' Reuters
01:09PM  New Legislation Targets Inversions From Different Angle at New York Times
12:46PM  Merck Pops On Good Profits, Tax Deal? at Barrons.com
09:38AM  Pfizer Beats on Q2 Earnings, Revs Despite Generic Pressures Zacks
12:00AM  Democrats Seek U.S. Contract Ban to Discourage Inversions at Bloomberg
28-Jul-14 05:30PM  Novartis Division Gets European Approval for Simbrinza Zacks
02:41PM  How Obama Could End Walgreen's Tax-Inversion Hopes at Investor's Business Daily
01:18PM  Pfizer Dips On BMO Downgrade at Barrons.com
12:35PM  Bankers push 'tax-dodge' M&A deals Reuters
11:46AM  AbbVie upgraded by UBS Briefing.com
11:20AM  UPDATE: UBS Upgrades AbbVie Benzinga
09:11AM  Will This Analyst Upgrade Help AbbVie (ABBV) Stock Today? at TheStreet
08:15AM  [video] Inversion shame gone: NYT reporter at CNBC
07:52AM  The Zacks Analyst Blog Highlights: Regions Financial, Federal National Mortgage Association, Wells Fargo, JPMorgan Chase and AbbVie Zacks
04:10AM  Obama Has The Power To Halt Tax Inversions In Their Tracks at Forbes
12:01AM  Obama could curb corporate 'inversions' on his own -ex-U.S. official Reuters
12:01AM  Lew Can Use Tax Rule to Slow Inversions, Ex-Official Says at Bloomberg
27-Jul-14 02:21AM  Obama Calls Offshore Deals 'Unpatriotic' Yet Funds, Investors, Boards Jump Aboard at Forbes
26-Jul-14 01:42PM  Walgreens eyes loophole end run around taxes at USA TODAY
03:05AM  Market Ignores AbbVie's Impressive Sales Due To Reliance On Humira at Seeking Alpha
25-Jul-14 03:39PM  [$$] Humira Sales Lift AbbVie Profit at The Wall Street Journal
02:46PM  Humira Still Key to AbbVie at Motley Fool
02:03PM  AbbVie profit beats estimates on surging Humira sales Reuters
01:35PM  [$$] Humira Sales Lift AbbVie Profit at The Wall Street Journal
12:52PM  [video] Obama Calls Congress to Take Action to Stop Inversions at TheStreet
11:46AM  AbbVie Beats Earnings Views, Sees Slower Humira Gain at Investor's Business Daily
10:52AM  AbbVie Q2 Earnings Top on Humira Sales, Shire In Focus Zacks
10:28AM  AbbVie profit beats estimates on surging Humira sales Reuters
10:12AM  How Will AbbVie (ABBV) Stock React To Its Second Quarter Earnings Beat? at TheStreet
09:54AM  Today's Top Health Care Headlines: AbbVie and GlaxoSmithKline at Motley Fool
09:42AM  AbbVie 2Q profit climbs 2.8 percent AP
09:07AM  MARK CUBAN: If Your Company Is Moving For Tax Reasons, I'm Selling Your Stock Business Insider
09:00AM  AbbVie Inc Earnings Call scheduled for 9:00 am ET today CCBN
08:54AM  Zacks Industry Outlook Highlights: Pfizer, AstraZeneca, AbbVie, Shire and Mylan Zacks
AbbVie Inc., a research-based biopharmaceutical company, is engaged in the discovery, development, manufacture, and sale of pharmaceutical products worldwide. Its product portfolio includes a range of adult and pediatric pharmaceuticals, including HUMIRA, a biologic therapy administered as a subcutaneous injection to treat various autoimmune diseases; Synthroid used in the treatment of hypothyroidism; AndroGel, a daily testosterone replacement therapy; Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Kaletra, a prescription anti-HIV-1 medicine used with other anti-HIV-1 medications to increase the chance of treatment response in people with HIV-1; Norvir , a protease inhibitor that is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection; and Lupron, a product for the palliative treatment of advanced prostate cancer. The company also offers TriCor and TRILIPIX, which are fibric acid derivatives that are indicated as adjuncts to diet to reduce total cholesterol, LDL cholesterol, and triglyceride levels; Niaspan, an extended release form of niacin that is indicated as an adjunct to diet to reduce total cholesterol, LDL cholesterol, and triglyceride levels, as well as to increase HDL cholesterol levels; Synagis, which protects at-risk infants from severe respiratory disease or respiratory syncytial virus; Sevoflurane, an anesthesia product for human use; Duodopa, a levodopa-carbidopa intestinal gel used to treat advanced Parkinson's disease; and Zemplar used for the prevention and treatment of secondary hyperparathyroidism. It sells its products to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its distribution centers and public warehouses. AbbVie Inc. was incorporated in 2012 and is based in North Chicago, Illinois. As of January 01, 2013, AbbVie Inc. operates independently of Abbott Laboratories.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GONZALEZ RICHARD AChairman of the Board and CEOMar 04Sale51.204,799245,706395,403Mar 04 05:13 PM
Schumacher Laura JEVP, Bus.Dev.,Ext.Aff.&GCMar 03Sale50.034,143207,284273,585Mar 04 05:18 PM
SALEKI-GERHARDT AZITASVP, OperationsMar 03Sale50.252,443122,76085,828Mar 04 05:17 PM
CHASE WILLIAM JEVP, Chief Financial OfficerMar 03Sale50.223,948198,259180,068Mar 04 05:12 PM
ALBAN CARLOSEVP, Commercial OperationsMar 03Sale50.092,882144,356205,138Mar 04 05:10 PM
HURWICH THOMAS A.VP, ControllerFeb 18Option Exercise44.939,138410,57061,016Feb 19 05:33 PM
Schumacher Laura JEVP, Bus.Dev.,Ext.Aff.&GCFeb 18Option Exercise43.218,928385,779256,224Feb 19 05:35 PM
RICHMOND TIMOTHY J.SVP, Human ResourcesFeb 18Sale51.2346523,82283,913Feb 19 05:35 PM
SALEKI-GERHARDT AZITASVP, OperationsFeb 10Option Exercise45.061,46666,05865,856Feb 12 04:49 PM
SALEKI-GERHARDT AZITASVP, OperationsFeb 05Sale47.8468732,86664,390Feb 07 05:08 PM
RICHMOND TIMOTHY J.SVP, Human ResourcesFeb 05Sale47.781,46069,76385,470Feb 07 05:08 PM